Abbott dives into EP market with 2 acquisitions

Candace Stuart | | Cardiovascular Business | Heart Rhythm

Abbott will buy two companies that develop electrophysiology products in a move designed to make Abbott a player in the catheter-based electrophysiology market. It also named a chief to lead the business.

The Abbott Park, Ill.-based healthcare company announced that it will acquire Topera, a private medical device company that specializes in diagnostic catheterization and software technology for treating patients with atrial fibrillation.

Topera’s rotor identification system assists during ablations by helping electrophysiologists identify and target heart tissue. Abbott will acquire outstanding equity of Topera for $250 million and will make potential future payments tied to performance milestones.

Abbott cited studies that showed the rotor identification system used with existing catheter ablation therapy had a single-procedure success rate of 87.5 percent in first ablation procedures and an 80.5 percent success rate at one-year follow-up.

Topera is headquartered in Menlo Park, Calif.

Abbott also will snap up ablation catheter developer Advanced Cardiac Therapeutics for an undisclosed amount. Advanced Cardiac Therapeutics makes a temperature-sensing catheter called TempaSure.

Advanced Cardiac Therapeutics is headquartered in Santa Clara, Calif.

Abbott tapped Michael Pederson, former president and chief executive officer of VytronUS, to lead the electrophysiology business.

Candace Stuart, Contributor

Related Content

Eko Health’s AI platform for digital stethoscopes granted new CPT code
Predicting sudden cardiac death after a heart attack may be impossible—for now
Concomitant ablation surgery during heart operations boosts long-term survival
Johnson & Johnson MedTech gains FDA approval for Varipulse PFA system
Boston Scientific agrees to acquire AFib ablation company
Heart Rhythm Society launches new group focused on EP advocacy

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup